Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -127,197 | -118,080 | -81,550 | -59,123 | -44,799 |
| Depreciation Amortization | 4,361 | 3,496 | 1,579 | 2,477 | 4,178 |
| Accounts receivable | -543 | 62 | -445 | 126 | 154 |
| Other Working Capital | 10,887 | 6,128 | 7,678 | 4,420 | 2,367 |
| Other Operating Activity | 13,605 | 6,857 | 5,069 | 2,318 | 2,442 |
| Operating Cash Flow | $-98,887 | $-101,537 | $-67,669 | $-49,782 | $-35,658 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -45,315 | -39,082 | -73,224 | -16,895 | -1,714 |
| PPE Investments | -4,876 | -1,929 | -4,198 | -85 | -441 |
| Investing Cash Flow | $-50,191 | $-41,011 | $-77,422 | $-16,980 | $-2,155 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 5,000 |
| Debt Repayment | N/A | N/A | -11,029 | -3,971 | -12,503 |
| Common Stock Issued | 193,151 | 1,171 | 301,100 | 83,784 | 36,023 |
| Other Financing Activity | 0 | 0 | -472 | -55 | -86 |
| Financing Cash Flow | $193,151 | $1,171 | $289,599 | $79,758 | $28,434 |
| Exchange Rate Effect | 15 | -5 | -3 | 2 | -9 |
| Beginning Cash Position | 28,020 | 169,402 | 24,897 | 11,899 | 21,287 |
| End Cash Position | 72,108 | 28,020 | 169,402 | 24,897 | 11,899 |
| Net Cash Flow | $44,088 | $-141,382 | $144,505 | $12,998 | $-9,388 |
| Free Cash Flow | |||||
| Operating Cash Flow | -98,887 | -101,537 | -67,669 | -49,782 | -35,658 |
| Capital Expenditure | -4,876 | -1,929 | -4,219 | -303 | -509 |
| Free Cash Flow | -103,763 | -103,466 | -71,888 | -50,085 | -36,167 |